EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Impact of SGLT2 inhibitors on urinary tract infections in patients with diabetes mellitus and ileal urinary diversion: a retrospective cohort study

Nicolas Arnold, Ruby Hischier, Mihai Dorin Vartolomei, Laila Schneidewind, Nicola Giudici, Raphael Röthlisberger, Bernhard Kiss, Beat Roth

International Urology and Nephrology · 2026

DOI: 10.1007/s11255-026-05175-4 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Urology and Nephrology, 2026. Verfasst von Nicolas Arnold und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Inselspital, University Hospital of Bern, Wilhelm-Fabry-Haus, 3010, Bern, Switzerland. nicolas.arnold@insel.ch. Hauptthemen laut MEDLINE: Urinary Tract Infections, Urinary Diversion, Sodium-Glucose Transporter 2 Inhibitors, Cystectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The impact of sodium–glucose linked transporter-2 inhibitors (SGLT2i) on urinary tract infection (UTI) risk remains uncertain and may be dose-dependent. No prior studies have evaluated their effect in patients with urinary diversion after cystectomy. This study evaluated the association between SGLT2i use and UTI in patients with diabetes mellitus (DM) after cystectomy and ileal urinary diversion.

Methods

We conducted a retrospective single-center cohort study including all patients with DM who underwent cystectomy with ileal urinary diversion between March 1996 and November 2023. Primary outcome was UTI occurrence, assessed by incidence rate and infection-free survival (IFS). Secondary outcomes included asymptomatic bacteriuria and glucosuria. UTI incidence rate was compared using Poisson regression. IFS was evaluated using Kaplan–Meier curves, log-rank test and Cox regression analysis.

Results

Among 123 included patients with DM and ileal urinary diversion, 18 (14.6%) received SGLT2i therapy. Median follow-up was 35 months (IQR 12–83). Overall, 121 UTI were documented, 6 (5.0%) in patients with and 115 (95.0%) without SGLT2i treatment, corresponding to incidence rates of 0.206 vs. 0.210 UTI/patient/year ( p = 0.959). Median IFS was 9 months (IQR 3–31) in the SGLT2i and 17 months (IQR 5–74) in the non-SGLT2i group, with no significant difference ( p = 0.489).

Conclusion

In this cohort, SGLT2i therapy was not associated with an increased risk of UTI in patients with DM and ileal urinary diversion after cystectomy. These findings suggest no evident signal for increased infection risk; however, prospective studies are warranted to confirm these observations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract InfectionsUrinary DiversionSodium-Glucose Transporter 2 InhibitorsCystectomyPostoperative ComplicationsHumansRetrospective StudiesFemaleMaleAgedMiddle AgedIncidenceCohort Studies

Stichwörter der Autor:innen

BacteriuriaCystectomyDiabetes MellitusGlucosuriaSodium-Glucose Transporter 2 InhibitorsUrinary DiversionUrinary Tract Infection

Substanzen

Sodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Urology, Inselspital, University Hospital of Bern, Wilhelm-Fabry-Haus, 3010, Bern, Switzerland. nicolas.arnold@insel.ch.
  • Department of Urology, Inselspital, University Hospital of Bern, Wilhelm-Fabry-Haus, 3010, Bern, Switzerland.
  • The Institution Organizing University Doctoral Studies (I.O.S.U.D.), 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca-Napoca, Romania.

Zitieren

APA

Arnold, N., Hischier, R., Vartolomei, M. D., Schneidewind, L., Giudici, N., Röthlisberger, R., Kiss, B., & Roth, B. (2026). Impact of SGLT2 inhibitors on urinary tract infections in patients with diabetes mellitus and ileal urinary diversion: a retrospective cohort study. International Urology and Nephrology. https://doi.org/10.1007/s11255-026-05175-4

Vancouver

Arnold N, Hischier R, Vartolomei MD, Schneidewind L, Giudici N, Röthlisberger R, et al. Impact of SGLT2 inhibitors on urinary tract infections in patients with diabetes mellitus and ileal urinary diversion: a retrospective cohort study. International Urology and Nephrology. 2026. doi:10.1007/s11255-026-05175-4

BibTeX
@article{Arnold2026,
  author = {Arnold, Nicolas and Hischier, Ruby and Vartolomei, Mihai Dorin and Schneidewind, Laila and Giudici, Nicola and Röthlisberger, Raphael and Kiss, Bernhard and Roth, Beat},
  title = {Impact of SGLT2 inhibitors on urinary tract infections in patients with diabetes mellitus and ileal urinary diversion: a retrospective cohort study},
  journal = {International Urology and Nephrology},
  year = {2026},
  doi = {10.1007/s11255-026-05175-4}
}
Kostenlos starten →